The Bottom Line Taken together, the Swedish and Japanese studies, along with decades of broader research, support a reassuring conclusion: there is no credible causal evidence linking typical acetaminophen use during pregnancy to autism, ADHD, or other neurodevelopmental disorders
A series of phase 3 clinical trials, including a heart health outcomes trial, are ongoing to test the safety and efficacy of the GLP-1 agonist in pill form
taking with food may reduce GI side effects Avoid late evening dosing in patients reporting agitation or insomnia Allow 4-12 weeks for initial pain benefit
In comparisons between tirzepatide and semaglutide, all doses of tirzepatide had similar risk profiles for gastrointestinal adverse events when compared with semaglutide 2.0 mg
Semaglutide is clinically indicated for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity such as Type 2 diabetes, hypertension, high cholesterol, or cardiovascular disease